RxDoctor Payments Data

Rebekah Doty

Family · Effingham, ILNPI 1790332450

Payments from drug & device makers

$2,665in general payments, 2019–2025

Across 159 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$677
  • AstraZeneca$277
  • Inspire Medical Systems, Inc.$266
  • GSK$262
  • Lilly USA, LLC$205
  • Novo Nordisk$124
  • plus $854 from 16 others

What the payments were for

  • Food & beverage$2,665100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,665 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin77$62,226
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$37,163
OzempicSemaglutide27$36,420
XareltoRivaroxaban43$35,587
TrulicityDulaglutide29$32,679
MounjaroTirzepatide20$27,990
FarxigaDapagliflozin Propanediol32$23,957
EliquisApixaban23$21,447
LinzessLinaclotide13$20,203
Breo ElliptaFluticasone/Vilanterol50$19,971
Incruse ElliptaUmeclidinium Bromide18$7,503
Albuterol Sulfate HfaAlbuterol Sulfate179$5,108
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$5,049
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate26$5,036
SymbicortBudesonide/Formoterol Fumarate19$4,275

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$262$64,637120 claims
Boehringer IngelheimJardiance$93$62,22677 claims
Lilly USA, LLCTrulicity, Mounjaro$205$60,66949 claims
Novo NordiskOzempic$124$36,42027 claims
AstraZenecaFarxiga, Symbicort$277$28,23251 claims
PfizerEliquis$116$21,44723 claims
AbbVieLinzess$677$20,20313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,941 family providers in Illinois.

Other family in Effingham

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →